0

baddrivers

Justices to rule on preemption of drug design defect claims 

  • by
    • November 30, 2012

The U.S. Supreme Court has agreed to decide whether federal law preempts state law design defect claims targeting generic pharmaceutical products.
The case from the 1st Circuit stems from a design defect claim brought by a woman who developed Steven Johnson Syndrome/Toxic Epidermal Necrolysis, a hypersensitivity disease that leads to » […]

Original post by http://lawyersusaonline.com/blog/2012/11/30/justices-to-rule-on-preemption-of-drug-design-defect-claims/

Report bad drivers!

Related posts:

  1. Justices to decide if Medicaid reimbursement law preempted  The U.S. Supreme Court will decide whether federal law prevents a state Medicaid program from taking one-third of an injured...
  2. ‘False’ sunscreen claims settled for $3 million to $10 million  Merck & Co has agreed to pay between $3 million and $10 million to settle a nearly decade old class-action...
  3. J&J unit settles state Risperdal claims for $181M  Johnson & Johnson has agreed to pay a record $181 million to settle claims brought by New York and 36...
  4. Vaccine Act bars parents’ wrongful death claims  The standards of the federal Vaccine Act applied to bar the wrongful death claims of the parents of a child...
  5. False arrest, beating claims settled for $500K  A Baltimore, Md. grandfather who was beaten while in jail with his wife on allegedly trumped-up charges of kidnapping their...

Leave a comment